Adenomas in women are more likely to appear flat on screening colonoscopy, according to researchers who say it is time to re-think how women are scoped for colorectal cancer (CRC).
Chemotherapy alone reduces risk of second cancers in Hodgkin’s
October 27, 2011 By Leave a Comment
Hodgkin’s lymphoma (HL) patients are less likely to develop a second malignancy if they are treated with chemotherapy alone than if radiotherapy is added, a large study has found.
Later presentation cause of poor outcomes with male breast cancer
October 27, 2011 By Leave a Comment
Male breast cancer patients have poorer survival than their female counterparts, but the difference is largely due to a later stage of presentation among men, research has shown.
Diabetes raises the risk of bowel cancer
October 20, 2011 By Leave a Comment
Diabetes is an independent risk factor for colorectal cancer, a new meta-analysis has found.
Intrauterine devices are shown to halve the risk of cervical cancer
October 20, 2011 By Leave a Comment
Women who use intrauterine contraceptive devices (IUDs) have half the risk of cervical cancer as never-users, new research has found.
Vaccination set to have a major impact on screening
September 19, 2011 By Leave a Comment
In his latest Clinical Update, Gary Culliton examines some recent developments in the area of cancer screening for women.
Risk of second cancers doubled in CLL patients
September 15, 2011 By Leave a Comment
The risk of second cancers in patients with chronic lymphocytic leukaemia is more than doubled compared to the general population, with the rate of melanoma increased seven-fold, a new study shows.
Inflammatory disease linked with ovarian cancer
September 9, 2011 By Leave a Comment
A history of pelvic inflammatory disease (PID) doubles the risk of ovarian cancer, a study suggests, raising hopes that many women could be diagnosed and treated for the deadly cancer earlier.
‘Impressive’ results with adoptive immunotherapy
September 8, 2011 By Leave a Comment
Cutting-edge therapy for chronic lymphoid leukaemia using genetically-modified autologous T cells has been successfully demonstrated in the medical literature, with a patient experiencing ongoing remission 10 months after treatment.
Some bisphosphonates may reduce risk of CRC by up to 50% — study
August 19, 2011 By Leave a Comment
Bisphosphonates appear to reduce a patient’s risk of colorectal cancer (CRC) by 16 per cent, with risedronate reducing it by up to 50 per cent, a trial has concluded.
Loading ...
